Figure 1.
Figure 1. Adenovirus-specific, serotype cross-reactive CTL line from donor AL. (A) At an E/T ratio of 20:1, the CTLs showed specific cytolytic activity against autologous adenovirus-infected targets in a standard chromium release assay with only slight or negligible killing of allogeneic, infected or uninfected targets or autologous fibroblasts alone. (B) Adenovirus-specific CTLs lysed autologous fibroblast targets transduced with Ad2, Ad4, Ad5, Ad6, Ad7, Ad8, and Ad11, but not allogeneic fibroblast targets, either alone or transduced with Ad5, Ad8, and Ad11.

Adenovirus-specific, serotype cross-reactive CTL line from donor AL. (A) At an E/T ratio of 20:1, the CTLs showed specific cytolytic activity against autologous adenovirus-infected targets in a standard chromium release assay with only slight or negligible killing of allogeneic, infected or uninfected targets or autologous fibroblasts alone. (B) Adenovirus-specific CTLs lysed autologous fibroblast targets transduced with Ad2, Ad4, Ad5, Ad6, Ad7, Ad8, and Ad11, but not allogeneic fibroblast targets, either alone or transduced with Ad5, Ad8, and Ad11.

Close Modal

or Create an Account

Close Modal
Close Modal